| scholarly article | Q13442814 |
| P50 | author | Luciana Giardino | Q72595903 |
| Alessandro Giuliani | Q43450479 | ||
| Alessandro Giuliani | Q56334659 | ||
| P2093 | author name string | N Carfagna | |
| L Aloe | |||
| A Battaglia | |||
| L Calza' | |||
| P2860 | cites work | Distribution and retrograde transport of trophic factors in the central nervous system: functional implications for the treatment of neurodegenerative diseases | Q33542013 |
| Neuroprotective strategy for Alzheimer disease: intranasal administration of a fatty neuropeptide | Q33628181 | ||
| The impact of L-arginine-nitric oxide metabolism on ischemia/reperfusion injury | Q33775207 | ||
| Cholecystokinin-8 regulation of NGF concentrations in adult mouse brain through a mechanism involving CCK(A) and CCK(B) receptors | Q35027347 | ||
| Trophic factor effects on cholinergic innervation in the cerebral cortex of the adult rat brain | Q35177362 | ||
| The mechanism of action of colchicine. Binding of colchincine-3H to cellular protein | Q36189186 | ||
| Neuronal dynamics and axonal flow. IV. Blockage of intra-axonal enzyme transport by colchicine | Q36450512 | ||
| Expanded distribution of mRNA for nerve growth factor, brain-derived neurotrophic factor, and neurotrophin 3 in the rat brain after colchicine treatment | Q37625508 | ||
| Neurochemical aspects on aging and diseases with cognitive impairment | Q37783361 | ||
| Role of neurotrophins in cholinergic-neurone function in the adult and aged CNS. | Q40397642 | ||
| Regulation of the cerebral microcirculation during neural activity: is nitric oxide the missing link? | Q40488700 | ||
| The Trk family of neurotrophin receptors | Q40590908 | ||
| Nerve growth factor pharmacology: application to the treatment of cholinergic neurodegeneration in Alzheimer's disease | Q40801515 | ||
| Neuroprotective effects of nicergoline in immortalized neurons | Q40962479 | ||
| Protective effects of nicergoline against hydrogen peroxide toxicity in rat neuronal cell line | Q41014285 | ||
| Hippocampal NGF levels are not reduced in the aged Fischer 344 rat. | Q41146600 | ||
| Thyroxine Increases Nerve Growth Factor Concentration in Adult Mouse Brain | Q41590726 | ||
| NOS induction by NGF in basal forebrain cholinergic neurones: evidence for regulation of brain NOS by a neurotrophin | Q42440949 | ||
| Distribution and relative density of p75 nerve growth factor receptors in the rat brain as a function of age and treatment with antibodies to nerve growth factor | Q42456906 | ||
| Tyrosine kinase A, galanin and nitric oxide synthase within basal forebrain neurons in the rat. | Q42461213 | ||
| Induction of nerve growth factor and basic fibroblast growth factor mRNA following clenbuterol: contrasting anatomical and cellular localization | Q72165161 | ||
| Effect of colchicine on transport of amine storage granules in sympathetic nerves of rat | Q72212000 | ||
| Thyroid hormone regulates NGF content and p75LNGFR expression in the basal forebrain of adult rats | Q73123578 | ||
| The role of the L-arginine/nitric oxide pathway in myocardial ischaemic and reperfusion injury | Q73204549 | ||
| Evidence that Alzheimer's disease is a microvascular disorder: the role of constitutive nitric oxide | Q73289699 | ||
| L-arginine treatment alters the kinetics of nitric oxide and superoxide release and reduces ischemia/reperfusion injury in skeletal muscle | Q73558507 | ||
| Age-related changes in rodent cortical acetylcholine and cognition: main effects of age versus age as an intervening variable | Q74634260 | ||
| Nitric oxide protects PC12 cells from serum deprivation-induced apoptosis by cGMP-dependent inhibition of caspase signaling | Q78094837 | ||
| Central neuronal loss and behavioral impairment in mice lacking neurotrophin receptor p75. | Q42466426 | ||
| Nicergoline stimulates protein kinase C mediated alpha-secretase processing of the amyloid precursor protein in cultured human neuroblastoma SH-SY5Y cells | Q42477374 | ||
| Immunohistochemical and neurochemical correlates of learning deficits in aged rats | Q42483907 | ||
| Lesion induced expression of low-affinity NGF-binding protein (p75) immunoreactivity after neonatal and adult aspiration lesions of the rat dorsomedial prefrontal cortex | Q42488735 | ||
| Exogenous administration of L-arginine protects cholinergic neurons from colchicine neurotoxicity | Q42489106 | ||
| Pituitary adenylate cyclase-activating polypeptide promotes the survival of basal forebrain cholinergic neurons in vitro and in vivo: comparison with effects of nerve growth factor | Q42492137 | ||
| Comparison of intracranial infusions of colchicine and ibotenic acid as models of neurodegeneration in the basal forebrain | Q42500804 | ||
| Acetylcholine synthesis and release following continuous intracerebral administration of NGF in adult and aged Fischer-344 rats. | Q42506907 | ||
| BDNF protection of basal forebrain cholinergic neurons after axotomy: complete protection of p75NGFR-positive cells | Q42512076 | ||
| Increased vulnerability of septal cholinergic neurons to partial loss of target neurons in aged rats | Q42527155 | ||
| BDNF and trkB mRNA expression in the hippocampal formation of aging rats | Q43544870 | ||
| Relationship of APP mRNA transcripts and levels of NGF and low-affinity NGF receptors to behavioral measures of age-related cognitive dysfunction | Q48144133 | ||
| Decreased level of nerve growth factor (NGF) and its messenger RNA in the aged rat brain | Q48181791 | ||
| Leukaemia inhibitory factor prevents loss of p75-nerve growth factor receptor immunoreactivity in medial septal neurons following fimbria-fornix lesions | Q48191476 | ||
| Janus faces of nitric oxide | Q48233596 | ||
| Presynaptic markers of cholinergic function in the rat brain: relationship with age and cognitive status | Q48238988 | ||
| Cholinergic deficits in aged rat brain are corrected with nicergoline | Q48321491 | ||
| Expression of BDNF and trkB as a function of age and cognitive performance | Q48351465 | ||
| Age-related changes in levels of brain-derived neurotrophic factor in selected brain regions of rats, normal mice and senescence-accelerated mice: a comparison to those of nerve growth factor and neurotrophin-3. | Q48353958 | ||
| Antioxidant properties of nicergoline; inhibition of brain auto-oxidation and superoxide production of neutrophils in rats | Q48430699 | ||
| Studies related to the use of colchicine as a neurotoxin in the septohippocampal cholinergic system | Q48432272 | ||
| Focal cerebral ischemia in rats induces expression of P75 neurotrophin receptor in resistant striatal cholinergic neurons | Q48475009 | ||
| The neurobiological effects of colchicine: modulation by nerve growth factor | Q48529234 | ||
| NGF improves spatial memory in aged rodents as a function of age. | Q48705015 | ||
| Topographic brain mapping of EEG after acute application of ergotalkaloids in the elderly | Q48935017 | ||
| Neurotoxic effects of colchicine: differential susceptibility of CNS neuronal populations | Q48972835 | ||
| NADPH diaphorase-containing striatal or cortical neurons are resistant to apoptosis | Q49122677 | ||
| Nicergoline: parallel evolution of clinical trial methodology and drug development in dementias. | Q52004888 | ||
| Nicergoline in senile dementia of alzheimer type and multi-infarct dementia: a double-blind, placebo-controlled, clinical and EEG/ERP mapping study | Q52019045 | ||
| Human nerve growth factor improves spatial memory in aged but not in young rats. | Q52057103 | ||
| Effects of nicergoline on age-related decrements in radial maze performance and acetylcholine levels. | Q52197285 | ||
| Simultaneous study of haemodynamic, metabolic and behavioural sequelae in a model of cerebral ischaemia in aged rats: effects of nicergoline. | Q52276861 | ||
| Oral administration of idebenone, a stimulator of NGF synthesis, recovers reduced NGF content in aged rat brain. | Q53208474 | ||
| Multiple sclerosis patients express increased levels of beta-nerve growth factor in cerebrospinal fluid | Q67984181 | ||
| Brain protection of nicergoline against hypoxia: EEG brain mapping and psychometry | Q68379662 | ||
| The calibration of 35S or 32P with 14C-labeled brain paste or 14C-plastic standards for quantitative autoradiography using LKB Ultrofilm or Amersham Hyperfilm | Q70142411 | ||
| Modulation of hippocampal ACh release by chronic nicergoline treatment in freely moving young and aged rats | Q70875695 | ||
| Modulation of phosphoinositide turnover by chronic nicergoline in rat brain | Q71337439 | ||
| A multicenter randomized double-blind study on the efficacy and safety of nicergoline in patients with multi-infarct dementia | Q71978842 | ||
| P433 | issue | 3 | |
| P407 | language of work or name | English | Q1860 |
| P1104 | number of pages | 11 | |
| P304 | page(s) | 487-497 | |
| P577 | publication date | 2002-01-01 | |
| P1433 | published in | Neuroscience | Q15708571 |
| P1476 | title | Neuroprotection and aging of the cholinergic system: a role for the ergoline derivative nicergoline (Sermion) | |
| P478 | volume | 109 |
| Q41472750 | Alteration in plasma and striatal levels of d-serine after d-serine administration with or without nicergoline: An in vivo microdialysis study |
| Q92358483 | Corneal Neuropathy: An Underrated Manifestation of Diabetes Mellitus |
| Q34771671 | Functional recovery of cholinergic basal forebrain neurons under disease conditions: old problems, new solutions? |
| Q37802919 | New therapeutic approaches in the treatment of diabetic keratopathy: a review |
| Q45711421 | Plasticity of GABA(a) system during ageing: focus on vestibular compensation and possible pharmacological intervention. |
| Q42876444 | Safety of nicergoline as an agent for management of cognitive function disorders. |
| Q46203782 | Spinal motoneurone distress during experimental allergic encephalomyelitis. |
| Q37230361 | Therapeutic use of nicergoline |
| Q44368398 | [1-13C]Glucose entry in neuronal and astrocytic intermediary metabolism of aged rats. A study of the effects of nicergoline treatment by 13C NMR spectroscopy. |
Search more.